Navigation Links
Arena Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference
Date:9/3/2009

SAN DIEGO, September 3, 2009 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that the company is scheduled to present at the Rodman & Renshaw Annual Global Investment Conference on September 9, 2009 at 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time) at the New York Palace Hotel in New York City. Robert E. Hoffman, Arena's Vice President, Finance and Chief Financial Officer, is scheduled to provide an overview of the company, including its clinical development and research programs.

A live audio webcast of the presentation will be available under the investor relations section of Arena's website at www.arenapharm.com. A replay of the presentation will be available for 30 days following the event. Please connect to Arena's website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for weight management. Arena has a broad pipeline of novel compounds targeting G protein-coupled receptors, an important class of validated drug targets, which includes compounds being evaluated independently and with partners, including Merck & Co., Inc., and Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the compan
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Arena Pharmaceuticals to Present at the Bear Stearns 20th Annual Healthcare Conference
2. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review
3. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
4. Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index
5. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Arena Pharmaceuticals to Report Third Quarter 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, October 17, 2007
7. Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results
8. Arena Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Arena Pharmaceuticals Appoints Phillip M. Schneider and Randall E. Woods to Board of Directors
10. Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity
11. Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... Caliper Life Sciences, Inc. (Nasdaq: CALP ), ... discovery and life sciences research, today introduced Living Image ... Image software drives the more than 800 Caliper IVIS ... features advanced spectral unmixing tools to enhance fluorescent sensitivity ...
(Date:12/2/2009)... Martek Biosciences Corporation (Nasdaq: MATK ) announced today ... quarter and fiscal year 2009 on December 16, 2009, at ... at 4:45 p.m. ET Martek will conduct a conference call ... may listen to the call live via webcast by visiting ...
(Date:12/2/2009)... Reportlinker.com announces that a new market research ... Neurostimulation - A Global Market Perspective ... The world neurostimulation market stands enthused by ... the resultant rise in age-related diseases such ...
(Date:12/2/2009)... YORK, Dec. 2 Reportlinker.com announces that ... in its catalogue: ,, Drug Discovery ... Trends & Opportunities ,, http://www.reportlinker.com/p0164246/Drug-Discovery-Technologies---A-Global-Update-of-Market-Trends--Opportunities.html ... integral and ongoing element of every pharmaceutical ...
Breaking Biology Technology:Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9
... U.S. Department of Energy,s Ames ,Laboratory have come ... and distribute ,the massive amounts of data that ... the world. The new technology, a three-dimensional photonic ... multiple ,wavelength channels (wavelengths of light) traveling along ...
... LLC.,today announced the addition of Mark Scherling to ... FCP as Program,Management Office and Siemens Practice Director., ... thought leadership,experience to FCP. Prior to joining FCP, ... at Catholic Healthcare West. Prior to that,responsibility, Mark ...
... England, February 18 Ranier Technology, a,Cambridge UK ... GBP8,million ($16 million) investment from new and existing ... spinal implant products.,The investment was made by Alliance ... the clinical testing and European launch of CAdisc ...
Other Biology Technology:New filter clears up fiber optic communications 2New filter clears up fiber optic communications 3FCP Welcomes Mark Scherling 2Ranier Technology Secures GBP8m Funding for its Cadisc Replacement Spinal Discs 2Ranier Technology Secures GBP8m Funding for its Cadisc Replacement Spinal Discs 3
(Date:12/2/2009)... consumption before head and neck cancer diagnosis strongly predicts ... studies. Now, results of a new study show a ... cancer diagnosis. , "Most cancer survivors are counseled to ... study, 21 percent continued to smoke even after their ...
(Date:12/2/2009)... secondhand smoke for a prolonged period of time and ... cancer, even in women who never smoked cigarettes themselves. ... smoke could increase risk of breast cancer is one ... scientist at the Northern California Cancer Center,s Berkeley office. ...
(Date:12/2/2009)... other foods have done more than raise public awareness and ... boom in the market for food testing equipment and fostering ... cover story in the current issue of Chemical & ... Editor Jyllian Kemsley and Senior Correspondent Marc Reisch point out ...
Breaking Biology News(10 mins):Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2ProUroCare Medical Completes Multiple Site Clinical Study for Imaging Prostate Abnormalities 5342 1ProUroCare Medical Completes Multiple Site Clinical Study for Imaging Prostate Abnormalities 5342 2ProUroCare Medical Completes Multiple Site Clinical Study for Imaging Prostate Abnormalities 5342 3Mirixa Corporation Announces Key Pharmacy Network Hire 5339 1Mirixa Corporation Announces Key Pharmacy Network Hire 5339 2AST on Capitol Hill to Promote Transplant Drug Extension Provision With Senate as Part of Health Care Reform 5336 1AST on Capitol Hill to Promote Transplant Drug Extension Provision With Senate as Part of Health Care Reform 5336 2
... susceptible cell, the human immunodeficiency virus hijacks that cell's ... HIV particles roll off the cellular assembly lines, burst ... to invade other cellular factories. Vanderbilt University Medical Center ... particle assembly. The findings, published March 11 in Cell, ...
... of scientists at The Scripps Research Institute is reporting ... research fundamental to everything from the normal processes that ... aberrant mechanisms that underlie many diseases, including cancer and ... RNA known as microRNA and their relationship to the ...
... of Applied Microbiology investigates how bacteria respond when they ... space stations, which feature lowered effects of gravity. , ... by Paul W. Baker and Laura G. Leff describes ... for some species, bacteria from the International Space Station ...
Other Biology News:Shutting down the HIV assembly line 2Cooperation is key—a new way of looking at MicroRNA and how it controls gene expression 2Cooperation is key—a new way of looking at MicroRNA and how it controls gene expression 3Cooperation is key—a new way of looking at MicroRNA and how it controls gene expression 4
A univariate (peak height or area) quantitative multi-component analysis package....
...
... Gene expression profiling allows a high-throuput ... that naturally occuring or artifitially induced changes ... in that system can be detected, studied, ... a broad range of genes at a ...
Rabbit polyclonal to Esa1 ( Abpromise for all tested applications)....
Biology Products: